Method and composition for cancer detection in humans

Details Method and composition for cancer detection in humans Method and composition for cancer detection in humans

A - Human Necessities

61

K

167/139, 167/48

A61K 51/10 (2006.01)

Patent

CA 1116081

ABSTRACT OF THE DISCLOSURE Anti-human chorionic gonadotropin (anti-hCG) and/or anti-human chorionic gonadotropin-beta subunit (anti-hCH-.beta.) labeled with Technetium-99m are/is administered to a human. The biodistribution of the labeled composition is monitored in order to determine whether the labeled composition accumulates at cancer sites, e.g. tumors that produce human chorionic gonado- tropin (hCG), human chorionic gonadotropin-like material, and a compound similar to and/or identical to the beta-chain of chorionic gonadotropin, or mixtures thereof which could bind specifically to anti-hCG and/or anti-hCG-.beta..

328078

Affiliated with

Also associated with

Rating

Method and composition for cancer detection in humans does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and composition for cancer detection in humans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for cancer detection in humans will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-805858